Lane, Giulia I. http://orcid.org/0000-0002-6977-5280
Mao-Draayer, Yang
Barboglio-Romo, Paholo
Clemens, J. Quentin
Gupta, Priyanka
Dunn, Rod
Qin, Yongmei
Cameron, Anne P.
Stoffel, John T.
Funding for this research was provided by:
Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Foundation (AWD011295, 2018 Study of Neuromodulation funded by Medtronic)
Article History
Received: 2 August 2019
Accepted: 14 May 2020
First Online: 27 May 2020
Ethics approval and consent to participate
: Institutional Review Board (Ethics approval) has been obtained for this study from the University of Michigan: HUM00153287. Participants will provide written informed consent prior to initiating in the study protocol. Amendments to IRB will be declared at final publication of study and on the trial registry.
: Not applicable.
: GL: no competing interests. YMD has served as a consultant and/or received grant support from: Acorda, Bayer Pharmaceutical, Biogen Idec, EMD Serono, Genzyme, Novartis, Questor, Chugai Pharmaceuticals, and Teva Neuroscience. Dr. Mao-Draayer is currently supported by grants from the NIH NIAID Autoimmune Center of Excellence: UM1-AI110557; NIH NINDS R01-NS080821, PCORI, Chugai, Novartis and Genzyme. PBR: no competing interests. QC: no competing interests. PG: no competing interests. RD: no competing interests. YQ: no competing interests. AC: reports personal fees from Wellspect, grants from Medtronic, outside of the submitted work. JS is supported by grants from the Department of Defense; received grant support from Ipsen, Uroplasty.